Work

Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia

Year: 2017

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of Cancer Research and Clinical Oncology

DOI: 10.1007/s00432-017-2385-7

Authors: Verena S. Hoffmann, Joerg Hasford, Michael Deininger, Jorge Cortes, Michele Baccarani, Rüdiger Hehlmann

Institutions: Ludwig-Maximilians-Universität München, University of Utah, Huntsman Cancer Institute, The University of Texas MD Anderson Cancer Center, University of Bologna, Heidelberg University, Medizinische Fakultät Mannheim

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2593434329

FWCI: 0.53

Cites: 39

Cited by: 18

Related to: 10